Every recall we track for Medtronic MiniMed — 30 in all — plus the complaints and injury reports the public filed about them.
Medtronic MiniMed recalls Guardian iOS and Android apps (v1.3.0) due to potential failure to upload glucose data, risking hypoglycemia or hyperglycemia. Affected users should check app version.
Medtronic recalls MiniMed 630G and 670G insulin pumps due to a cybersecurity vulnerability that could allow unauthorized insulin delivery, risking hypoglycemia or hyperglycemia. Affected models include MiniMed 630G/ MMT-1715, MMT-1755, MMT-1754 and MiniMed 670G/ MMT-1780, MMT-1781, MMT-1782, MMT-1760, MMT-1761, MMT-1762, MMT-1740, MMT-1741, MMT-1742.
Medtronic recalls MiniMed 620G and 640G insulin pumps due to a cybersecurity vulnerability that could allow unauthorized insulin delivery, risking hypoglycemia or hyperglycemia. Learn what to do.
Medtronic MiniMed insulin pumps provide precise insulin delivery for diabetes management. Learn more about MiniMed insulin pumps and their features.
Medtronic MiniMed
Medtronic MiniMed insulin pumps are designed for patients with diabetes to provide precise insulin delivery and continuous glucose monitoring.
Recall of Medtronic MiniMed 780G Insulin Pumps (O.U.S. Version) due to battery cap deterioration causing potential power loss. Affected units have specific serial numbers and UDI codes listed in the recall notice.
Medtronic MiniMed recalls 720G insulin pumps (O.U.S. version) due to battery cap deterioration causing potential power loss. Affected units have specific product numbers and UDI codes listed.
Medtronic MiniMed 670G insulin pumps (U.S. and O.U.S. versions) may have battery cap deterioration causing power loss. Affected units include specific model numbers and serials listed in the recall. Stop using immediately to prevent insulin pump failure.
Medtronic recalls MiniMed 740G insulin pumps (O.U.S. version) due to battery cap deterioration causing potential power loss. Affected units have specific serial numbers; contact Medtronic for details.
Medtronic MiniMed recalls 640G insulin pumps (O.U.S. Version) due to battery cap deterioration that may cause power loss. Affected units have specific serial numbers listed in the recall notice. Stop using immediately if you own one of these models.
Medtronic MiniMed 630G and 670G insulin pumps sold in last 6 months may not deliver basal insulin without proper setup, risking severe hyperglycemia and diabetic ketoacidosis. Affected units have serial numbers from NG2056884H to NG2891033H (US) or NG1921788H to NG2883091 (OUS).
Medtronic MiniMed recalls specific 780G insulin pump models due to a software issue that may cause insulin over-delivery if a user delivers an additional bolus after a large insulin delivery. Affected units include models with serial numbers starting with NG2357677H and others listed in the recall.
Medtronic MiniMed recalls specific 670G insulin pump models due to a software issue that may cause insulin over-delivery if a user adds an additional bolus after a large insulin delivery. Affected models include PUMP MMT-1740KX 670G V6.3 SF MG CLIN and others with serial numbers listed.
Medtronic recalls Paradigm insulin pumps (MMT-523, software 2.4A or lower) due to wireless cybersecurity risks allowing unauthorized insulin control.
Medtronic recalls insulin pumps with model MMT-723K and software versions 2.4A or lower due to potential cybersecurity vulnerabilities allowing unauthorized remote control of insulin delivery.
Medtronic recalls Paradigm insulin pumps (MMT-522K) due to wireless cybersecurity risks that could allow unauthorized access to insulin delivery settings.
Medtronic MiniMed Paradigm Veo insulin pumps with model numbers MMT-554CM and MMT-754CM (software versions 2.7A or lower) are recalled due to potential cybersecurity vulnerabilities that could allow unauthorized remote control of insulin delivery.
Medtronic recalls Paradigm insulin pumps (MMT-722K) due to wireless cybersecurity risks allowing unauthorized insulin delivery changes. Affected users should contact Medtronic for security updates.
Medtronic recalls Paradigm insulin pumps (MMT-722) due to wireless cybersecurity risks allowing unauthorized remote control of insulin delivery.
Medtronic recalls all MiniMed Paradigm 511 insulin pumps due to potential cybersecurity vulnerabilities that could allow unauthorized remote control of insulin delivery.
Medtronic recalls Paradigm insulin pumps (MMT-712E) due to wireless cybersecurity risks that could allow unauthorized access to insulin settings.
Medtronic recalls MiniMed Paradigm insulin pumps (MMT-712) due to wireless cybersecurity risks that could allow unauthorized insulin delivery changes.
Medtronic recalls all Paradigm 512 insulin pumps due to potential cybersecurity vulnerabilities that could allow unauthorized remote control of insulin delivery.
Medtronic recalls insulin pumps with model numbers MMT-554 and MMT-754 (software 2.6A or lower) due to potential cybersecurity vulnerabilities that could allow unauthorized remote control of insulin delivery.
Medtronic recalls Paradigm insulin pumps (MMT-522) due to wireless cybersecurity risks allowing unauthorized control of insulin delivery. Affected users should contact Medtronic for guidance.
Medtronic recalls MiniMed MMT-508 insulin pumps due to wireless security risks that could allow unauthorized access to change insulin settings.
Medtronic MiniMed Paradigm insulin pumps (MMT 515, MMT-715) face cybersecurity risks allowing unauthorized remote control of insulin delivery. Affected users should contact Medtronic for guidance.
Medtronic recalls Paradigm insulin pumps with model MMT-523K and software versions 2.4A or lower due to potential cybersecurity vulnerabilities allowing unauthorized remote control of insulin delivery.
Medtronic recalls Paradigm insulin pumps (MMT-723, software 2.4A or lower) due to wireless cybersecurity risks that could allow unauthorized insulin delivery changes.
